4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-16-146208
Chief Operating Officer sold 483 shares at $2.45 ($1,184)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keuer Thomas A Chief Operating Officer | 2016-10-18 | Sale | −483 | $2.45 | $1,184 | 14,900 | D |
| Open-market sales · 483 sh · avg $2.45 · $1,184 | |||||||
Loading xslF345X03/doc4.xml…